tradingkey.logo
tradingkey.logo

Oryzon Announces US Patent Grant Covering Iadademstat Combinations For AML

ReutersMar 23, 2026 6:36 AM

- Oryzon Genomics SA ORY.MC:

  • ANNOUNCES U.S. PATENT GRANT COVERING IADADEMSTAT COMBINATIONS WITH VENETOCLAX

  • KEY COMBINATION FOR THE TREATMENT OF FIRST-LINE ACUTE MYELOID LEUKEMIA (AML)

  • PATENT EXPECTED TO EXPIRE IN JAN 2039

Source text: https://tinyurl.com/yb5rkhfj

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI